Table: Pharmarise Holdings -2024/25 group results

Pharmarise Holdings

25/06/2025 09:10

Jun 25 (Reuters)- 
          Pharmarise Holdings Corp 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT    
              May 31, 2025    May 31, 2024   May 31, 2026     YEAR      
                 LATEST         YEAR-AGO        COMPANY       COMPANY   
                 RESULTS         RESULTS       FORECAST     H1 FORECAST 
  Sales           63.51           54.47          66.80         33.14    
               (+16.6 pct)     (+4.7 pct)     (+5.2 pct)    (+8.5 pct)  
  Operating      293 mln         916 mln          1.12        390 mln   
               (-67.9 pct)     (-36.3 pct)   (+282.2 pct)  (+287.2 pct) 
  Recurring      136 mln         833 mln        941 mln       363 mln   
               (-83.6 pct)     (-41.8 pct)   (+587.3 pct)               
  Net
  Net         loss 367 mln    loss 351 mln      266 mln       99 mln    
  EPS        loss 32.48 yen  loss 33.41 yen    23.45 yen     8.80 yen   
  Ann Div       14.00 yen       20.00 yen      14.00 yen                
  -Q2 Div          NIL             NIL            NIL                   
  -Q4 Div       14.00 yen       20.00 yen      14.00 yen                
  
  NOTE - Pharmarise Holdings Corp.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2796.T